PADMAJA J.A.S's most recent trade in Cohance Lifesciences Ltd. was a Disposal of 28,000 Equity Shares done at an average price of Rs. 501.8 . Disclosure was reported to the exchange on Aug. 14, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for PADMAJA J.A.S in the Trendlyne database.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cohance Lifesciences | PADMAJA J.A.S | Directors Immediate Relative | Disposal | 14 Aug 2023 | 28,000 | 0 (0%) | 0.01% | 501.8 | 14,049,630 | 11 Aug 2023 11 Aug 2023 |
Insider Trading | Equity Shares | Market Sale |
Cohance Lifesciences | PADMAJA J.A.S | Directors Immediate Relative | Disposal | 17 Feb 2023 | 7,000 | 28,000 (0.01%) | 0.00% | 482.2 | 3,375,726 | 15 Feb 2023 16 Feb 2023 |
Insider Trading | Equity Shares | Market Sale |
Cohance Lifesciences | PADMAJA J.A.S | Directors Immediate Relative | Acquisition | 02 Sep 2020 | 5,000 | 17,500 (0.01%) | 0.00% | 640.6 | 3,203,198 | 31 Aug 2020 31 Aug 2020 |
Insider Trading | Equity Shares | Market Purchase |
Cohance Lifesciences | PADMAJA J.A.S | Directors Immediate Relative | Acquisition | 31 Aug 2020 | 2,500 | 12,500 (0.01%) | 0.00% | 688.2 | 1,720,386 | 28 Aug 2020 28 Aug 2020 |
Insider Trading | Equity Shares | Market Purchase |
Cohance Lifesciences | PADMAJA J.A.S | Directors Immediate Relative | Acquisition | 27 Aug 2020 | 5,000 | 10,000 (0.01%) | 0.00% | 702.8 | 3,514,022 | 26 Aug 2020 26 Aug 2020 |
Insider Trading | Equity Shares | Market Purchase |
Cohance Lifesciences | PADMAJA J.A.S | Directors Immediate Relative | Acquisition | 24 Aug 2020 | 5,000 | 5,000 (0%) | 0.00% | 685.7 | 3,428,711 | 21 Aug 2020 21 Aug 2020 |
Insider Trading | Equity Shares | Market Purchase |